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Introduction
Problem:
- Pt w/ chronic rhinosinusitis want/need surgery (ESS)
- Comorbid OSA
- Higher risk of perioperative complications
- Less probability of achieving QoL improvement
- Underdiagnosed and often undiagnosed
- Requires a sleep study (expensive) for diagnosis
- It is unclear who benefits from screening
Introduction
• STOP-BANG – widely accepted OSA screening tool
– Not universal in the setting endoscopic sinus surgery (FESS)
• SNOT-22 - a standard survey for endoscopic sinus surgery 
patients (given pre/post ESS)
– Surveys outcomes for several domains of quality of life
– Rhinologic, extranasal rhinologic, ear/facial, psych dysfxn sleep dyfxn
• Can SNOT-22 be used as a screening tool?
– Specifically, the sleep domain?
– Would be good triage tool for sleep-study
– OSA screening can be done w/ minimal practice change




• Q: Can SD-SNOT-22 score predict OSA 
incidence in patients with chronic 
rhinosinusitis following surgery?
• H: High SD-SNOT score is positively predictive 
of OSA incidence of OSA in CRS patients 
following surgery 3 months postoperatively.
Approach & Results
• Retrospective chart review of 200-300 patients from 11/2019 –
1/2020
– Data source: TJUH ENT patients, from database of ESS patients
• Split into 2 groups – Dx'd OSA & non-OSA – compared SNOT-22 
score / STOP-BANG (if present)
– Obtain sleep domain of SNOT-22 scores of pre-ESS and 3mo post-ESS 
SNOT score
• Compare post-op CRS patient with vs without OSA diagnosis 
(control)
– Is there a range/cutoff sleep domain score that is significantly 
associated w/ OSA diagnosis?
Approach & Results
• Analysis 
– SD-SNOT was higher in OSA group preoperatively
• 22.4±12.9 vs. 14.7±11.4; p=0.02
– SD-SNOT was higher in OSA group postoperatively
• 20.8±15.0 vs. 6.8±8.6; p=0.02
- STOP-BANG was NOT significantly higher in OSA group, 
preoperatively 
– STOP-BANG was significantly higher OSA group, postoperatively
• 6.5±0.7 vs. 1.8±0.7; p=0.02
- Further analysis of STOP-BANG not performed due to lack of 
administration (n=17)
Approach & Results
• Calculated SD-SNOT-22 cutoffs for OSA
– Fischer-exact chi square
• Preoperative – 21 (OR:3.5; CI:1.1-10.7; p=0.02)
• Postoperative – 16 (OR 10.5; CI;1.3-83.5; p=0.03)
Tested association of OSA diagnosis with SD score pre-op
SD Score P Value Odds Ratio 95% CI
Less than 19 vs. 
More than 19
0.06
Less than 20 vs. 
More than 20
0.04* 3.5 1.1-10.7




Variable Non-OSA OSA P value
Age 48.44 ± 18.19 57.2 ± 9.49 0.04*
BMI 27.33±6.21 40.71±40.69 <0.0001*






Facial domain at 3m 2.67±3.93 3.33±2.73 0.17




STOP-BANG score 2.00±1.2 4.33±2.01 0.001*
• Group comparison 2 mo post-ESS (Kruskal Wallis)
Approach & Results
QoL improvement comparison between groups
• Delta SNOT score, post-ESS 3 mo (Kruskal Wallis)










10.52±15.27 3.91±7.54 1.41±3.28 4.72±8.22 0.45±1.91
OSA
(Mean ± SD)
11.33±15.87 4.66±7.20 3.83±2.63 1.5±7.68 1.33±1.96
P value 0.82 0.85 0.04* 0.22 0.36
Approach & Results







• SD-SNOT-22 of 21 pre-operatively and 16 post-
operatively indicates underlying OSA
• Likely better as a rule-out tool
– Similar to STOP-BANG practically speaking
• No other study documents SNOT-22 use for 
this purpose
• Underdiagnosis itself was a limitation
• Utility: improved screening with zero change 
to perioperative procedure
Future Directions
• Retroactive application of the test to address 
potential underdiagnosis in populations
• Incorporate of screening into perioperative 
care, universally
• Replication in a “less underdiagnosed” 
population?
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